Biotech 365

Main menu

Skip to primary content
Skip to secondary content
  • Biotech 365
    • Contact
    • Offers
  • Biotech Companies
  • Database researchers
    • BioLeads
  • BioMarketplace
  • Biotech Jobs
  • Biopharma News

Tag Archives: Karsten Munk KNUDSEN

Innate Pharma – therapeutic antibodies

Posted on 2015-05-26 by Biotech365

Innate Pharma is a biopharma company developing therapeutic antibodies for the treatment of cancer and inflammatory diseases.

Innate Pharma – therapeutic antibodies

innate pharma
Continue reading →

Posted in Biotech Companies, Biotech Companies France | Tagged ADC, ADCs, Alessandro Moretta, antibody drug conjugates, bacterial transglutaminase, Bernard MALISSEN, BTG, cancer, Catherine MOUKHEIBIR, chronic inflammatory diseases, cytotoxic antibodies, cytotoxic antibody, David RAULET, Eric Vivier, François Romagné, Gilles BRISSON, Hervé Brailly, immune cells, immune oncology, immuno-oncology, immunomodulating antibodies, immunomodulating antibody, inflammatory disease, inflammatory diseases, innate immunity, innate immunity cells, Innate Pharma, Innate Pharma - therapeutic antibodies, Irina STAATZ-GRANZER, Jean-Jacques Fournié, Jérôme TIOLLIER, Karsten Munk KNUDSEN, Marc Bonneville, Marcel ROZENCWEIG, Michael CALIGIURI, monoclonal antibodies, monoclonal antibody, Nicolai WAGTMANN, Patrick LANGLOIS, pharmacodynamics, pharmacotoxicology, Philip GREENBERG, Philippe POULETTY, Pierre DODION, Ron LEVY, therapeutic antibodies, therapeutic antibody, transglutaminase, Véronique CHABERNAUD, Yannis MOREL
Contact                       Offers                      
Proudly powered by WordPress